NCIt related terms : placebo therapy; sham therapy;
NCIt definition : An inactive substance, treatment or procedure that is intended to provide baseline
measurements for the experimental protocol of a clinical trial.;
Alternative definition : CDISC-GLOSS: A pharmaceutical preparation that does not contain the investigational
agent and is generally prepared to be physically indistinguishable from the preparation
containing the investigational product.; NCI-GLOSS: An inactive substance or treatment that looks the same as, and is given
the same way as, an active drug or treatment being tested. The effects of the active
drug or treatment are compared to the effects of the placebo.; MRCT-Ctr: Something that looks like the treatment being studied, but doesn't contain
any medicine. (https://mrctcenter.org/glossaryterm/placebo/);
NCI Metathesaurus CUI : CL473981;
Codes from synonyms : CDR0000046688; CDR0000045078; CDR0000522478;
https://www.cochrane.org/fr/CD014089/MUSKEL_quels-sont-les-benefices-et-les-risques-des-medicaments-qui-augmentent-le-flux-sanguin-vers-les 2023 United Kingdom review of literature french abstract Ratio secondary raynaud's phenomenon Increased Current Reformed Smoker, Years Unknown increased vascular flow risks and benefits Fear Score 5 Medication Placebo raynaud disease What Month is it Loss of Chromosome 5 Intensity and Distress 5 drug, nos Flow Extremities Clinical Status Ordinal Scale Outcome 5 extremities Version research report ECOG Performance Status 5 anthelmintics Severity of Symptom Score 5 No Flow Thought Score 5 raynaud phenomenon Death Related to Adverse Event Agreement Score 5 Illness Intrusiveness Rating 5 Raynaud Phenomenon Gleason Grade Group 5 risk assessment placebos Phase V Trial Regulatory Report Phosphodiesterase Inhibitor Neck Pain Score 5 phosphodiesterase 5 inhibitors Upset Score 5 albumin/globulin ratio Increase Flux GDC Therapeutic Agent Terminology